Chris Armstrong currently serves as the Head of In Vivo at Benchling, where roles also include Leader of Studies and Strategy Lead. Prior experience includes a tenure at Queen's University Belfast as a Visiting Scientist, Prostate Cancer UK Travelling Prize Fellow, and Postdoctoral Researcher, focusing on prostate cancer radiation biology. Prior to Benchling, Chris co-founded and served as CEO of Overwatch Research, a company dedicated to improving experiment management for scientific researchers, which was acquired by Benchling. Educational achievements comprise a Ph.D. in prostate cancer research and a B.Sc. in Biomedical Sciences from Queen's University Belfast, as well as early education at Bangor Grammar School.
This person is not in the org chart
This person is not in any teams
This person is not in any offices